跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,926 条关于
“Hanmi Pharmaceuticals”
全部
8,926
临床试验
531
药物
1,737
机构
2,049
资讯
4,609
去年
FDA Rejects Poziotinib for HER2-Mutated NSCLC Following Advisory Committee's Negative Vote
去年
Hanmi's BH3120 Shows Promise in Early Clinical Trials for Advanced Solid Tumors
去年
Hanmi Pharmaceutical Advances BH3120 Immunotherapy Trials Targeting Solid Tumors
去年
Hanmi's BH3120 Shows Promise in Phase 1 Trials for Advanced Solid Tumors
2年前
GLP-1 Therapies Emerge as Promising Treatment for MASH, Survodutide and Tirzepatide Show Potential
去年
Hanmi Pharmaceutical Fast-Tracks Efeglenatide Launch for Obesity Treatment
11天前
Hanmi Pharmaceutical to Fully Deploy AI Across Quality Assurance, Training on 4,000 SOPs
去年
Hanmi Pharmaceutical Advances Six New Drugs into Clinical Trials Targeting Hypertension, Diabetes, and Cancer
9个月前
Hanmi Pharmaceutical's HM16390 Shows Dual Mechanism for Enhanced Cancer Immunotherapy Safety and Efficacy
9个月前
Hanmi Pharmaceutical's Efeglenatide Receives Fast Track Designation for Obesity Treatment in South Korea
第 1 页,共 461 页
上一页
下一页